By Reuters and published by CNA
ASTRAZENECA said on Tuesday (May 7) it had initiated the worldwide withdrawal of its Covid-19 vaccine due to a “surplus of available updated vaccines” since the pandemic.
The company also said it would proceed to withdraw the vaccine Vaxzevria’s marketing authorisations within Europe.
“As multiple, variant Covid-19 vaccines have since been developed there is a surplus of available updated vaccines,” the company said, adding that this had led to a decline in demand for Vaxzevria, which is no longer being manufactured or supplied.
According to media reports, the Anglo-Swedish drugmaker has previously admitted in court documents that the vaccine causes side effects such as blood clots and low blood platelet counts.
The firm’s application to withdraw the vaccine was made on Mar. 5 and came into effect on May 7, according to the Telegraph, which first reported the development.
The British newspaper said the legal document, submitted in February as part of class action lawsuit proceedings, stated that the company’s vaccine “can, in very rare cases, cause TTS”.
According to the World Health Organization (WHO), the condition known as thrombotic thrombocytopenia syndrome is a “serious and life-threatening adverse event”.
Singapore has not authorised the use of AstraZeneca’s Covid-19 vaccine. Health Minister On Ye Kung said this in a parliamentary reply in April 2023.
He was responding to a question about the withdrawal of the AstraZeneca jab in Australia due to concerns about thrombosis.
London-listed AstraZeneca began moving into respiratory syncytial virus vaccines and obesity drugs through several deals last year after a slowdown in growth as Covid-19 medicine sales declined.
Dr Pavitra Mohan, paediatrician, public health expert, and co-founder of Basic Healthcare Services in India said, “Astra Zeneca’s admission does underscore the need for transparent communication by the pharmaceuticals and vaccine developers. There is no need to worry based on this information. The side effects are rare and were seen only in young people and only within 4 to 6 weeks of the first dose of vaccination. So, there is no need for panic,” Business Standard reported
CAPTIONS:
Top: Syringes with needles are seen in front of a displayed AstraZeneca logo in this illustration taken on Nov. 27, 2021. Photo: Reuters/Dado Ruvic and published by CNA
Front Page: The AstraZeneca vaccine. Photo: Thai Rath
Also read: Concern over spread of Covid-19, nearly 10,000 cases a day
65 children infected with Rotavirus after playing at Songkran foam party
Phumtham dared to serve cabinet members 10-year-old rice from govt stock
Govt dared to dismiss Central Bank Governor over digital wallet row
Commerce chambers oppose nationwide 400-baht daily minimum wage
Myanmar social media: Thaksin held talks with ethnic armed groups, govt in exile
As temperature exceeds 43°C woman loses her entire durian crop
One Reply to “AstraZeneca withdraws Covid-19 vaccine globally months after admitting to side effects”